Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

European CHMP recommends approval of Merck & Co.'s fertility treatment Elonva

Nov. 23, 2009

Sirona Biochem reports results from phase III trial of dapagliflozin in diabetes type 2

Nov. 23, 2009

Vitae discloses 11beta-HSD1 inhibitors for the treatment of diabetes

Nov. 23, 2009

Atorvastatin improves eGFR regardless of metabolic syndrome state in CHD patients

Nov. 23, 2009

Afexa Life Sciences starts clinical trial of LIP-01 for reducing blood lipids

Nov. 23, 2009

FDA grants priority review to Actelion's sNDA for miglustat in NP-C

Nov. 23, 2009

Insulin secretion stimulators described by Merck KGaA for the treatment of hyperglycemia

Nov. 20, 2009

Chugai files for additional indication for Epogin in Japan

Nov. 19, 2009

Vivus reports results from phase III avanafil study in erectile dysfunction

Nov. 19, 2009

Favorable safety and lipid profiles with anacetrapib therapy in hyperlipidemia

Nov. 19, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...